PubRank

M A Kamm

Author PubWeight™ 274.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent pain and faecal urgency after stapled haemorrhoidectomy. Lancet 2000 7.09
2 Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993 5.74
3 Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004 3.80
4 Prospective comparison of faecal incontinence grading systems. Gut 1999 3.48
5 Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 3.01
6 Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ 1994 2.75
7 Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 1997 2.38
8 Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004 2.29
9 Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009 2.20
10 AGA technical review on anorectal testing techniques. Gastroenterology 1999 2.05
11 Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994 2.04
12 Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993 2.01
13 Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil 2011 1.99
14 Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg 2004 1.84
15 The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003 1.84
16 Long-term clinical outcome of surgery for solitary rectal ulcer syndrome. Br J Surg 1998 1.80
17 Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Colorectal Dis 2007 1.78
18 Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009 1.75
19 Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br J Surg 2002 1.75
20 Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut 2001 1.75
21 Bowel dysfunction in spinal-cord-injury patients. Lancet 1996 1.74
22 Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 2003 1.73
23 Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet 2000 1.72
24 Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997 1.71
25 Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut 1993 1.71
26 Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet 2000 1.69
27 Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg 1994 1.67
28 Migration and maturation of human colonic dendritic cells. J Immunol 2001 1.64
29 The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007 1.64
30 Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004 1.63
31 Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 2000 1.61
32 Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 1996 1.60
33 An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology 2001 1.57
34 'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg 1994 1.55
35 Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005 1.49
36 A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 2008 1.49
37 Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study. Gut 2001 1.48
38 Solitary rectal ulcer syndrome. Br J Surg 1998 1.48
39 Internal anal sphincter repair. Int J Colorectal Dis 1997 1.47
40 Gender differences in the longitudinal pressure profile of the anal canal related to anatomical structure as demonstrated on three-dimensional anal endosonography. Br J Surg 2000 1.46
41 Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon. Gastroenterology 1992 1.44
42 Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther 2011 1.43
43 Postoperative recurrence of Crohn's disease: impact of endoscopic monitoring and treatment step-up. Colorectal Dis 2013 1.42
44 Effect of age, sex and parity on anorectal function. Br J Surg 1994 1.42
45 Low dose interferon gamma for refractory Crohn's disease. Ital J Gastroenterol Hepatol 1997 1.41
46 Anterior anal sphincter repair in patients with obstetric trauma. Br J Surg 1994 1.41
47 Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut 1998 1.39
48 Myopathy of internal anal sphincter with polyglucosan inclusions. J Pathol 1990 1.39
49 Anal endosonography in the investigation of faecal incontinence. Br J Surg 1991 1.37
50 Intestinal pseudo-obstruction with deficient smooth muscle alpha-actin. Histopathology 1992 1.37
51 Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006 1.36
52 Topical glyceryl trinitrate in the treatment of chronic anal fissure. Br J Surg 1996 1.35
53 Anal endosonography and correlation with in vitro and in vivo anatomy. Br J Surg 1993 1.35
54 The normal range and a simple diagram for recording whole gut transit time. Int J Colorectal Dis 1992 1.33
55 Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder. Gut 2001 1.32
56 Pudendal nerve damage during labour: prospective study before and after childbirth. Br J Obstet Gynaecol 1994 1.31
57 Lateral ligament division during rectopexy causes constipation but prevents recurrence: results of a prospective randomized study. Br J Surg 1991 1.29
58 Effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinence. Gut 1999 1.28
59 MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Aliment Pharmacol Ther 2007 1.28
60 Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate. Gut 1999 1.27
61 Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers. Gut 1998 1.26
62 Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy. Lancet 1998 1.23
63 Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997 1.22
64 Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994 1.22
65 Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther 2011 1.22
66 DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997 1.19
67 Permanent sacral nerve stimulation for fecal incontinence. Ann Surg 2000 1.19
68 Endosonography of the anal sphincters: normal anatomy and comparison with manometry. Clin Radiol 1994 1.18
69 Sphincter injury after anal dilatation demonstrated by anal endosonography. Br J Surg 1991 1.17
70 Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000 1.16
71 Relationship of symptoms in faecal incontinence to specific sphincter abnormalities. Int J Colorectal Dis 1995 1.16
72 Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 2002 1.15
73 Unsuspected sphincter damage following childbirth revealed by anal endosonography. Br J Radiol 1991 1.14
74 Confirmation of endosonographic detection of external anal sphincter defects by simultaneous electromyographic mapping. Br J Surg 1991 1.14
75 Faecal incontinence after childbirth. Br J Obstet Gynaecol 1997 1.13
76 Controlled randomised trial of visual biofeedback versus muscle training without a visual display for intractable constipation. Gut 1995 1.13
77 Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 2002 1.13
78 Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 2005 1.13
79 Prospective study of the extent of internal anal sphincter division during lateral sphincterotomy. Dis Colon Rectum 1994 1.12
80 Adrenergic control of the internal anal sphincter is abnormal in patients with idiopathic faecal incontinence. Br J Surg 1990 1.12
81 The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003 1.12
82 Injectable bulking agents for treating faecal incontinence. Br J Surg 2005 1.11
83 Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther 2002 1.11
84 Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence. Lancet 1997 1.11
85 Randomized trial of open versus closed day-case haemorrhoidectomy. Br J Surg 1999 1.11
86 The role of the gut flora in health and disease, and its modification as therapy. Aliment Pharmacol Ther 2002 1.10
87 MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Aliment Pharmacol Ther 2008 1.10
88 Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2005 1.09
89 Anal sphincter trauma during instrumental delivery. Int J Gynaecol Obstet 1993 1.09
90 Anal endosonography for identifying external sphincter defects confirmed histologically. Br J Surg 1994 1.09
91 Anal sphincter biofeedback and pelvic floor exercises for faecal incontinence in adults--a systematic review. Aliment Pharmacol Ther 2001 1.09
92 A comparison between electromyography and anal endosonography in mapping external anal sphincter defects. Dis Colon Rectum 1990 1.07
93 Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002 1.07
94 Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 1990 1.07
95 Retracted Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction. Gut 2002 1.07
96 Clinical, physiological, and radiological study of a new purpose-designed artificial bowel sphincter. Lancet 1998 1.07
97 Ileoanal pouch compliance and motor function. Br J Surg 1992 1.07
98 Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol 1994 1.06
99 Colectomy for idiopathic megarectum and megacolon. Gut 1991 1.05
100 Results of the Duhamel operation in the treatment of idiopathic megarectum and megacolon. Br J Surg 1991 1.05
101 Lower gastrointestinal malignancy in Crohn's disease. Gut 1994 1.05
102 Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000 1.05
103 Medium-term results of permanent sacral nerve stimulation for faecal incontinence. Br J Surg 2002 1.04
104 Laser Doppler measurement of rectal mucosal blood flow. Gut 1999 1.04
105 Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease. Aliment Pharmacol Ther 2000 1.04
106 Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004 1.04
107 Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci 1993 1.03
108 Gastrointestinal transit and prolonged ambulatory colonic motility in health and faecal incontinence. Gut 1997 1.02
109 Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001 1.02
110 Predictive value of impaired evacuation at proctography in diagnosing anismus. AJR Am J Roentgenol 2001 1.01
111 Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000 1.01
112 Psychological morbidity in women with idiopathic constipation. Am J Gastroenterol 2000 1.01
113 Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation. Inflamm Bowel Dis 2010 1.01
114 Gut mucosal response to food antigens in Crohn's disease. Aliment Pharmacol Ther 2002 1.00
115 Perineal examination as a predictor of underlying external anal sphincter damage. Br J Obstet Gynaecol 1997 1.00
116 The internal and sphincter--new insights into faecal incontinence. Gut 1991 1.00
117 Factors affecting continence after surgery for anal fistula. Br J Surg 1994 1.00
118 Double-blind crossover study of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 2000 1.00
119 Behavioural therapy (biofeedback) for solitary rectal ulcer syndrome improves symptoms and mucosal blood flow. Gut 2004 0.99
120 Intra-abdominal and pelvic abscess in Crohn's disease: results of noninvasive and surgical management. Br J Surg 1998 0.99
121 Clinical features of idiopathic megarectum and idiopathic megacolon. Gut 1997 0.99
122 Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial. Dis Colon Rectum 2001 0.99
123 Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence. Gut 1994 0.99
124 Proctographic features of anismus. Radiology 1995 0.99
125 A randomized, controlled trial of diathermy hemorrhoidectomy vs. stapled hemorrhoidectomy in an intended day-care setting with longer-term follow-up. Dis Colon Rectum 2003 0.98
126 Prospective evaluation of the treatment of solitary rectal ulcer syndrome with biofeedback. Gut 1997 0.98
127 Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Aliment Pharmacol Ther 2006 0.97
128 Vaginal endosonography. New approach to image the undisturbed anal sphincter. Dis Colon Rectum 1994 0.97
129 Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. Gut 1993 0.95
130 Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 1999 0.95
131 Long-term results of postanal repair for neurogenic faecal incontinence. Br J Surg 1994 0.95
132 Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness. Inflamm Bowel Dis 2011 0.95
133 Symposium on constipation. Int J Colorectal Dis 1992 0.95
134 Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995 0.94
135 Abnormal internal anal sphincter fibrosis and elasticity in fecal incontinence. Dis Colon Rectum 1995 0.94
136 Sacral nerve stimulation for faecal incontinence in the UK. Br J Surg 2004 0.94
137 Colorectal and anal motility during defaecation. Lancet 1992 0.94
138 Pathology of idiopathic megarectum and megacolon. Gut 1997 0.94
139 Abdominal rectopexy for complete prolapse: prospective study evaluating changes in symptoms and anorectal function. Dis Colon Rectum 1992 0.93
140 Relationship between anatomic and symptomatic long-term results after rectocele repair for impaired defecation. Dis Colon Rectum 1999 0.93
141 Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: a 10-year cohort analysis. Colorectal Dis 2007 0.93
142 Long-term results of perianal silicone injection for faecal incontinence. Colorectal Dis 2007 0.92
143 Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies. Aliment Pharmacol Ther 2007 0.92
144 Outcome of biofeedback for faecal incontinence. Br J Surg 1999 0.92
145 Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis 2010 0.92
146 Economic evaluation of sacral nerve stimulation for faecal incontinence. Br J Surg 2008 0.92
147 Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003 0.91
148 Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis. Aliment Pharmacol Ther 2003 0.91
149 Dilated stomach and weak muscles. Lancet 2000 0.91
150 Proctocolectomy with restorative ileoanal reservoir for severe idiopathic constipation. Report of two cases. Dis Colon Rectum 1988 0.90
151 Pathology of the rectal wall in solitary rectal ulcer syndrome and complete rectal prolapse. Gut 1996 0.90
152 Survey of laxative use by adults with self-defined constipation in South America and Asia: a comparison of six countries. Aliment Pharmacol Ther 2009 0.90
153 Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 2002 0.89
154 Life events in patients with vulvodynia. BJOG 2008 0.89
155 Topical diltiazem and bethanechol decrease anal sphincter pressure without side effects. Gut 1999 0.89
156 Abnormal visceral autonomic innervation in neurogenic faecal incontinence. Gut 1993 0.89
157 Altered contractile proteins and neural innervation in idiopathic megarectum and megacolon. Histopathology 1998 0.89
158 Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome. Aliment Pharmacol Ther 2008 0.89
159 Double-blind placebo-controlled crossover study of sacral nerve stimulation for idiopathic constipation. Br J Surg 2002 0.89
160 Results of stoma formation for idiopathic megarectum and megacolon. Int J Colorectal Dis 1992 0.89
161 Solitary rectal ulcer and complete rectal prolapse: one condition or two? Int J Colorectal Dis 1995 0.89
162 Effects of loperamide on ileoanal pouch function. Br J Surg 1998 0.89
163 Changes in anal anatomy following vaginal delivery revealed by anal endosonography. Br J Obstet Gynaecol 1999 0.89
164 Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003 0.88
165 Results of behavioral treatment (biofeedback) for solitary rectal ulcer syndrome. Dis Colon Rectum 2001 0.88
166 Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology 1990 0.87
167 Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Aliment Pharmacol Ther 2008 0.87
168 Enkephalins modulate inhibitory neuromuscular transmission in circular muscle of human colon via delta-opioid receptors. J Physiol 1990 0.87
169 Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion 1997 0.87
170 Transperineal repair of symptomatic rectocele with Marlex mesh: a clinical, physiological and radiologic assessment of treatment. J Am Coll Surg 1996 0.87
171 Rectal sensory evoked potentials: an assessment of their clinical value. Int J Colorectal Dis 1993 0.87
172 A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease. Mucosal Immunol 2012 0.86
173 Intractable vomiting due to a brainstem lesion in the absence of neurological signs or raised intracranial pressure. Gut 1998 0.86
174 Physiological, psychological and behavioural characteristics of men and women with faecal incontinence. Colorectal Dis 2008 0.86
175 Review article: Population screening for colorectal cancer. Aliment Pharmacol Ther 2005 0.86
176 Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction. Dis Colon Rectum 2000 0.85
177 Reproducible assessment of vaginal and rectal mucosal and skin blood flow: laser doppler fluximetry of the pelvic microcirculation. Clin Sci (Lond) 2000 0.85
178 Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas. Aliment Pharmacol Ther 2009 0.85
179 Immune sensitization to food, yeast and bacteria in Crohn's disease. Aliment Pharmacol Ther 2001 0.85
180 Pathophysiology and management of bowel dysfunction in multiple sclerosis. Eur J Gastroenterol Hepatol 2001 0.85
181 A case of factitious colonic bleeding. J R Soc Med 1990 0.85
182 Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation. Am J Gastroenterol 1998 0.84
183 The acute effect of straining on pelvic floor neurological function. Int J Colorectal Dis 1994 0.84
184 Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum 1995 0.84
185 Prospective assessment of the clinical value of anorectal investigations. Digestion 2000 0.84
186 Anal plug for faecal incontinence. Colorectal Dis 2001 0.84
187 Ambulatory pouch and anal motility in patients with ileo-anal reservoirs. Int J Colorectal Dis 1994 0.83
188 Effect of different infusion regimens on colonic motility and efficacy of colostomy irrigation. Br J Surg 1996 0.83
189 Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 1994 0.83
190 Effect of pregnancy on anal sphincter morphology and function. Int J Colorectal Dis 1993 0.83
191 A winking anus may signify spinal injury. Gut 2001 0.83
192 Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin Exp Immunol 2004 0.82
193 Three-dimensional endoanal sonography in assessing anal canal injury. Br J Surg 1999 0.82
194 Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012 0.82
195 Oesophageal epithelial innervation in health and reflux oesophagitis. Gut 1999 0.82
196 Gastrointestinal transit in patients with idiopathic megarectum. Dis Colon Rectum 1996 0.82
197 Gastric compliance, sensation, and the relaxation response to a nitric oxide donor in health and reflux oesophagitis. Digestion 2000 0.82
198 Electrogastrography in chronic intestinal pseudoobstruction. Dig Dis Sci 1996 0.82
199 Results of repeat anal sphincter repair. Br J Surg 1999 0.81
200 Treatment of constipation in adults associated with idiopathic megarectum by behavioural retraining including biofeedback. Colorectal Dis 2002 0.81
201 A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis. Clin Exp Immunol 2009 0.81
202 Azathioprine dose escalation in inflammatory bowel disease. Aliment Pharmacol Ther 2004 0.81
203 Relationship of small bowel motility to ileoanal reservoir function. Gut 1994 0.81
204 Surgical management of severe idiopathic constipation: a review. Neth J Surg 1991 0.81
205 Enteric innervation in idiopathic megarectum and megacolon. Int J Colorectal Dis 1996 0.81
206 Contribution of gastrointestinal transit and pouch characteristics in determining pouch function. Gut 1997 0.81
207 The anal sphincter in idiopathic megarectum: effects of manual disimpaction under general anesthetic. Dis Colon Rectum 1996 0.81
208 Bowel dysfunction in young women with urinary retention. Gut 1993 0.81
209 Magnetic resonance imaging of the pelvic floor in patients with obstructed defaecation. Br J Surg 1997 0.81
210 Prospective assessment of accuracy of endoanal MR imaging and endosonography in patients with fecal incontinence. AJR Am J Roentgenol 2000 0.80
211 Recent advances in the surgical treatment of faecal incontinence. Br J Surg 1998 0.80
212 Partial colectomy and coloanal anastomosis for idiopathic megarectum and megacolon. Dis Colon Rectum 1992 0.80
213 Clinical and economic evaluation of surgical treatments for faecal incontinence. Br J Surg 2001 0.80
214 Relationship between parity and anal manometry. Dis Colon Rectum 1993 0.80
215 Endocoil magnetic resonance imaging quantification of external anal sphincter atrophy. Br J Surg 2001 0.80
216 Effect of sacral nerve stimulation on autonomic nerve function. Br J Surg 2003 0.80
217 Transvaginal versus anal endosonography for detecting damage to the anal sphincter. AJR Am J Roentgenol 1997 0.80
218 Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. Br J Surg 2005 0.79
219 Ghrelin augments afferent response to distension in rat isolated jejunum. Neurogastroenterol Motil 2006 0.79
220 Pouch dynamics--a simple test of ileo-anal pouch evacuation. Int J Colorectal Dis 1991 0.79
221 Relationship between gut-specific autonomic testing and bowel dysfunction in spinal cord injury patients. Spinal Cord 2009 0.79
222 Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis. Aliment Pharmacol Ther 2008 0.79
223 Non-surgical management of faecal incontinence. Hosp Med 2001 0.78
224 Symptomatic gastroesophageal reflux in acutely hospitalized patients. Dig Dis Sci 1999 0.78
225 Decreased sensitivity of muscarinic but not 5-hydroxytryptamine receptors of the internal anal sphincter in neurogenic faecal incontinence. Br J Surg 1992 0.78
226 Fecal incontinence. Gastroenterol Clin North Am 2001 0.78
227 Morbidity, mortality, and risk factors for esophagitis in hospital inpatients. J Clin Gastroenterol 2000 0.78
228 Review article: the management of constipation in adults. Aliment Pharmacol Ther 1993 0.78
229 Prospective evaluation of intestinal homing memory T cells in ulcerative colitis. Inflamm Bowel Dis 2004 0.77
230 Working Party report: defecation disorders. Am J Gastroenterol 1994 0.77
231 Recent developments in CT colonography. Clin Radiol 2005 0.77
232 Investigation of faecal incontinence. Hosp Med 2001 0.77
233 Surgery for idiopathic megarectum and megacolon. Int J Colorectal Dis 1991 0.77
234 Internal anal sphincter myopathy causing proctalgia fugax and constipation: further clinical and radiological characterization in a patient. Eur J Gastroenterol Hepatol 1997 0.77
235 Civilian and war injuries of the perineum and anal sphincters. Br J Surg 1994 0.77
236 Effect of sacral neuromodulation for faecal incontinence on sexual activity. Colorectal Dis 2005 0.77
237 Reassessing artificial bowel sphincters. Lancet 2000 0.77
238 Assessment of external anal sphincter morphology in idiopathic fecal incontinence with endocoil magnetic resonance imaging. Dig Dis Sci 2001 0.76
239 Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice. Intern Med J 2014 0.76
240 Prospective assessment of interobserver agreement for endoanal MRI in fecal incontinence. Abdom Imaging 2001 0.76
241 Treatment of impaired defecation associated with rectocele by behavorial retraining (biofeedback). Dis Colon Rectum 2000 0.76
242 Improving the efficacy of sacral nerve stimulation for faecal incontinence by alteration of stimulation parameters. Br J Surg 2009 0.76
243 An in vitro electrophysiological study of the colon from patients with idiopathic chronic constipation. Clin Auton Res 1992 0.76
244 Outcome of behavioural treatment for idiopathic chronic constipation. Intern Med J 2014 0.76
245 Dynamic cystoproctography and physiological testing in women with urinary stress incontinence and urogenital prolapse. Clin Radiol 1996 0.75
246 Behavioural treatment (biofeedback) for constipation following hysterectomy. Br J Surg 2000 0.75
247 Neuropeptides in the internal anal sphincter in neurogenic faecal incontinence. Int J Colorectal Dis 1993 0.75
248 The value of age of onset and rectal emptying in predicting the outcome of colectomy for severe idiopathic constipation. Int J Colorectal Dis 1992 0.75
249 Effect of acute changes in sacral nerve stimulation amplitude on anorectal function in faecal incontinence. Colorectal Dis 2000 0.75
250 Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli. J Clin Gastroenterol 1996 0.75
251 Pathogenesis of Crohn's disease. Lancet 1992 0.75
252 Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis. Eur J Gastroenterol Hepatol 1998 0.75
253 Sphincteroplasty for incontinence after surgery for idiopathic fistula in ano. Int J Colorectal Dis 1997 0.75
254 Evaluation of specific herpes DNA viruses in idiopathic megarectum and idiopathic megacolon. Int J Colorectal Dis 1998 0.75
255 Unwanted anal penetration as a physical cause of faecal incontinence. Eur J Gastroenterol Hepatol 1995 0.75
256 Notice of withdrawal. Gut 2006 0.75
257 Fundal gastritis as a potential cause of reflux oesophagitis. Dis Esophagus 2000 0.75
258 An extra-ordinary cause of megacolon. Lancet 1997 0.75
259 A radiopaque marker technique for measuring gastrointestinal transit in subjects with an ileostomy. Dig Dis Sci 1996 0.75
260 Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Int J Clin Pract 2007 0.75
261 Novel drug therapies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995 0.75